Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
2004 StandoutNobel
A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
2003
The diversity and breadth of cancer cell fatty acid metabolism
2021
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
2011 Standout
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
ZD1839: targeting the epidermal growth factor receptor in cancer therapy
2002
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
2015
Growth inhibition of cervical cancer cells by the human retinoic acid receptor β gene
2000
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Cancer chemoprevention with dietary phytochemicals
2003 Standout
The tor pathway: a target for cancer therapy
2004 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth
2003
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
2016
Delivery materials for siRNA therapeutics
2013 Standout
MicroRNAs: small RNAs with a big role in gene regulation
2004 Standout
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Macrocephaly and the control of brain growth in autistic disorders
2005
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
2005 StandoutNature
MicroRNA biogenesis: coordinated cropping and dicing
2005 Standout
Cancer stem cells revisited
2017 Standout
Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid
2006
The circadian clock: pacemaker and tumour suppressor
2003
IFNs, ISGylation and cancer: Cui prodest?
2012
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Calcium, protease action, and the regulation of the cell cycle
1998
Altering Chemosensitivity by Modulating Translation Elongation
2009
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
2015 StandoutNobel
Targeting RAS signalling pathways in cancer therapy
2003 Standout
The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration
2006
Oncomirs — microRNAs with a role in cancer
2006 Standout
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Mechanisms of smoking-related lung and pancreatic adenocarcinoma development
2002
Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase
2003
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
2005 Standout
Opposing Effects of Retinoic Acid on Cell Growth Result from Alternate Activation of Two Different Nuclear Receptors
2007
Nuclear factor-kappa B and cancer: its role in prevention and therapy
2002
Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth
2005 StandoutNobel
Epidermal growth factor receptor tyrosine kinase inhibitors
2002
The PI3K Pathway in Human Disease
2017 Standout
Knocking down barriers: advances in siRNA delivery
2009 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?☆
2006
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Differentiation therapy of leukemia: 3 decades of development
2009
Targeting the epidermal growth factor receptor in non-small cell lung cancer.
2003
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Advances in the Biology of Lung Cancer Chemoprevention
2005
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance
2016 StandoutNobel
Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis
2003
Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells
2004
Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
2002
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Suppression of Mammary Carcinoma Growth by Retinoic Acid: Proapoptotic Genes Are Targets for Retinoic Acid Receptor and Cellular Retinoic Acid–Binding Protein II Signaling
2005
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas
2007
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
2008
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Works of David Sekula being referenced
Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia
2010
G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program
2016
UBE1L causes lung cancer growth suppression by targeting cyclin D1
2008
Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target
2012
Retinoic Acid Promotes Ubiquitination and Proteolysis of Cyclin D1 during Induced Tumor Cell Differentiation
1999
Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function
2001
Cyclin degradation for cancer therapy and chemoprevention
2007
Cyclin D1 Proteolysis: a Retinoid Chemoprevention Signal in Normal, Immortalized, and Transformed Human Bronchial Epithelial Cells
1999
Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.
2002
Retinoid Targeting of Different D-Type Cyclins through Distinct Chemopreventive Mechanisms
2005
UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia
2002
Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy
2004
Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
1997